United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1,678 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 215,508 | 237,929 |
| Total Cites | 520 | 539 |
| H-index | 9 | 9 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 344 | 350 |
| Number of Single+First+Last Authored Papers | 7 | 7 |
| Total Cites to Single+First+Last Authored Papers | 344 | 350 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 468 | 476 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
3.53%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1,546 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 205,089 | 207,839 |
| Total Cites | 509 | 545 |
| H-index | 9 | 9 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 355 | 369 |
| Number of Single+First+Last Authored Papers | 6 | 6 |
| Total Cites to Single+First+Last Authored Papers | 355 | 369 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 465 | 476 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.14 |
| Self-Citation Percentage |
6.61%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1,730 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 221,211 | 243,756 |
| Total Cites | 529 | 553 |
| H-index | 7 | 7 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 385 | 395 |
| Number of Single+First+Last Authored Papers | 6 | 6 |
| Total Cites to Single+First+Last Authored Papers | 385 | 395 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 490 | 500 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.11 |
| Self-Citation Percentage |
4.34%
|
|
Rosenblum, Daniel
NYU Grossman School of Medicine,
2022 Rank: 198,591
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1,561 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 198,591 | 227,274 |
| Total Cites | 508 | 537 |
| H-index | 8 | 8 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 360 | 374 |
| Number of Single+First+Last Authored Papers | 5 | 5 |
| Total Cites to Single+First+Last Authored Papers | 360 | 374 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 463 | 476 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
5.40%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.